Previous Article | Next Article ![]()
Journal of Bacteriology, May 2003, p. 3049-3059, Vol. 185, No. 10
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.10.3049-3059.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and the Plant Molecular Biology/Biotechnology Program, The Ohio State University, Columbus, Ohio 43210-1292
Received 10 January 2003/ Accepted 6 March 2003
|
|
|---|
|
|
|---|
More recently, the completion of several genome projects offered further indications that euryarchaea contain putative RubisCO genes that encode proteins, distinguished from the aforementioned form I and form II enzymes. These proteins are different enough from form I and form II RubisCO that they have been classified as a separate type or form III enzyme (30, 34, 35). The first two archaeal sequencing projects showed RubisCO homologues in the genomes of Methanococcus jannaschii and Archaeoglobus fulgidus (2, 14). M. jannaschii is an obligately autotrophic methanogen, and A. fulgidus is a sulfate-reducing organism (12, 39). Both organisms are obligate anaerobes growing at thermophilic temperatures and are clearly different from typical organisms known to fix carbon dioxide by the CBB pathway. Indeed, there are good indications that the route for primary CO2 fixation in these organisms involves a modified acetyl-coenzyme A pathway, with no indications of CBB-dependent CO2 fixation (28, 39). In addition to these organisms, genomic sequencing projects indicate that Pyrococcus, renamed Thermococcus (6, 13, 16), also contains form III enzymes, with the Thermococcus enzyme forming an interesting and unique quaternary structure (13).
The existence of RubisCO proteins in archaea is not limited to thermophilic organisms. The completed genomes of the Methanosarcina acetivorans (9), Methanosarcina mazei (4), and Methanosarcina barkeri (http://www.jgi.doe.gov/JGI_microbial/html/methanosarcina/methano_homepage.html) mesophilic heterotrophic methanogens were also found to contain genes encoding putative RubisCO proteins. Regardless of growth temperature or nutritional requirements, these archaeal genome projects uncovered for the first time RubisCO genes in organisms that evolved in the absence of molecular oxygen. This discovery could have significant impact on understanding the principles behind CO2/O2 discrimination by RubisCO, which is a fundamental issue in RubisCO enzymology. Certainly, it now appears that examples of RubisCO sequences are widespread in the third domain of life, yet it is also true that Methanobacterium thermoautotrophicum (26) and Methanococcus maripaludis(http://www.genome.washington.edu/UWGC/methanococus/) do not contain recognizable RubisCO sequences.
The expression of archaeal RubisCO genes from extreme thermophiles in Escherichia coli, and the subsequent purification of the resultant recombinant protein, has shown that the archaeal protein catalyzes bona fide RubisCO activity (35). The ability to catalyze the reaction at extreme temperatures is an indication of a unique structural adaptation which could provide insights into general structure-function relationships for all RubisCO molecules. Unlike the reported properties of the Thermococcus kodakaraensis KOD1 enzyme (6, 16), the properties of all of the RubisCO proteins described in this paper include sensitivity to oxygen, suggesting that the archaeal RubisCO form III enzymes represent an extremely diverse group with respect to catalytic function (30). Although the archaeal enzymes have been shown to catalyze the bona fide RubisCO reaction, there is neither convincing biochemical evidence that archaea use the CBB pathway for CO2 fixation nor any evidence from genome sequences, other than the earlier report of PRK activity in extracts of extreme halophiles (1), for the existence of a gene encoding PRK. There has also been no suggestion or evidence to indicate that there are other means to produce RuBP, the substrate for RubisCO. Thus, the physiological role of RubisCO in archaea remains to be determined. As a first step in approaching this conundrum, it was deemed important to demonstrate that the archaeal enzymes are synthesized and active in the native organism. The work reported here shows that extracts from four different archaeal organisms unequivocally catalyze RuBP-dependent CO2 fixation. Western blot analyses showed that the RubisCO gene in M. jannaschii is expressed under normal growth conditions, and radiometric assays demonstrated that the RubisCO molecules were assembled in a catalytically active state in all four organisms. Furthermore, the mesophilic RubisCO gene from M. acetivorans afforded the opportunity to complement RubisCO deletion strains of the photosynthetic bacteria Rhodobacter capsulatus and Rhodobacter sphaeroides. The complementation data, together with the in vitro demonstration of RubisCO activity, provides a strong argument that the form III RubisCO proteins have the ability to catalyze a physiologically significant RuBP-dependent CO2 fixation reaction.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Strict anaerobic procedures were used in the preparation of medium for M. jannaschii, A. fulgidus, M. barkeri, and M. acetivorans. All gases were passed through heated copper filings to remove trace amounts of oxygen. A. fulgidus was grown in lactate-sulfate medium with a gas phase of 80% N2-20% CO2 (39). The organism was grown in crimped tubes or 160-ml serum vials that were pressurized to 30 lb/in2. Growth took place in a nonshaking heating oven set to a constant temperature of 85°C. M. jannaschii was grown in serum vials with either the bicarbonate medium (12) or MES (morpholineethanesulfonic acid)-buffered medium (19) in an atmosphere of 80% H2-20% CO2 at 30 lb/in2 at 85 or 65°C. M. acetivorans was grown in HS medium supplemented with either methanol or methanol-acetate in sealed crimped tubes (27) with an atmosphere of 80% H2-20% CO2 at 10 lb/in2 at 37°C without shaking. M. barkeri cells (grown on either methanol or trimethylamines) were a kind gift from J. A. Krzycki.
Cultures were harvested anaerobically in mid to late logarithmic growth by centrifugation. The cells were washed in their respective media to prevent osmotic lysis and centrifuged again at 16,000 x g for 30 min at 4°C. Cell pellets were stored at -70°C in sealed centrifuge bottles.
DNA manipulations and genetic techniques. To construct an M. jannaschii RubisCO expression plasmid without the previously employed N-terminal His tag (35), primers were designed with an NdeI site at the N terminus (5'GGAATTCCATATGGACTACATAAACTTAAACTACA3') and a TAA stop codon at the C terminus (5'TTATTTCCAATACTCTAAAGCC3'). Using PFU turbo polymerase (Stratagene) and these primers, the M. jannaschii RubisCO gene (Mj 1235) was amplified from pAMJEV50 (The Institute for Genomic Research, Rockville, Md.). The 1.4-kb PCR fragment was cloned into the NdeI and SmaI sites of pK19. The gene was fully sequenced to ensure that no mutations were introduced during the PCR. The M. jannaschii RubisCO gene was subsequently subcloned into the NdeI and BamHI sites of expression plasmid pET11A (Stratagene).
The A. fulgidus RubisCO gene (Af 1638) was cloned directly from genomic DNA. PFU polymerase (NdeI [5'GGAATTCCATATGGCGGAGTTTGAGATTTACAGA3'] and BamHI [5'ATTTTAGATTGGCGTAACCCTG3']) and primers designed with an NdeI restriction site at the N terminus and a BamHI site at the C terminus were used to amplify the rbcL-2 gene from A. fulgidus genomic DNA. The gene was ligated into pCR Script (Stratagene) and sequenced for PCR-incorporated mutations. Using the NdeI and BamHI sites in that vector, the gene was subcloned into pET11A.
Using UniPol DNA polymerase (PGC Scientific, Frederick, Md.) with primers that contained an AflIII site at the 5' end and a BglII site at the 3' end (AflII primer, 5'ACATGTCCAGGTACTTCCTCCAGCCAG and BglII primer, 5'AGATCTGTGCAGCCGCTCATTATGCAG), the putative RubisCO gene from M. acetivorans (Ma 4555) was amplified from genomic DNA. The amplified gene was ligated into pCR Topo 2.1 and fully sequenced. Using the AflIII and BglII sites, the 1.4-kb fragment was directionally cloned into pET11D (Stratagene). A 200-bp deletion at the N-terminal end of the M. acetivorans rbcL gene was used to inactivate the rbcL gene in its host as described by William Metcalf (personal communication) (18); the resultant double-recombinant knockout strain of M. acetivorans was used to test for any possible growth phenotype.
Using XbaI and SpeI restriction sites for expression in Rhodobacter, the putative rbcL gene from M. acetivorans was further subcloned from pCR Topo 2.1 (Invitrogen, Carlsbad, Calif.) into pRPSMCS3, a broad-host-range expression vector (S. A. Smith and F. R. Tabita, unpublished studies). Using helper plasmid pRK2013 for complementation of mutant strains, the pRPSMCS3-rbcL construct (pRPSMCS3MA) was conjugated into R. capsulatus strain SBI-II and R. sphaeroides strain 16 by triparental matings as previously described (8).
Cell lysis procedures for preparing crude extracts from archaeal cells. Cells were normally lysed in the anaerobic chamber by a combination of osmotic shock and disruption using glass beads, except for M. barkeri cells, which were lysed solely by osmotic shock. Cell pellets were resuspended in oxygen-free 50 mM Tris-Cl (pH 7.2)-1 mM EDTA-10 mM MgCl2-10 mM sodium bicarbonate-10 mM ß-mercaptoethanol (TEMMB buffer) with DNase and acid-washed 100-micron glass beads and lysed for approximately 2 min in a Mini-Bead Beater (Biospec Products, Bartlesville, Okla.) set at 4,800 rpm. The cell lysate was centrifuged at 13,500 x g inside the chamber for 20 min. The supernatant was removed, and the contents were sealed inside a 2-ml serum vial under argon.
Cell extracts were desalted using 2.5-ml HiTrap desalting columns (Amersham Pharmacia, Piscataway, N.J.). Column fractions of 1 ml were taken, and protein was detected by continuous flow measurements at an absorbance of 280 nm. Fractions containing protein were pooled and aliquoted into 1-ml serum vials under argon and either immediately used or frozen in an ethanol dry-ice bath and stored at -70°C.
Synthesis and purification of recombinant RubisCO. The A. fulgidus rbcL2 (isolated by J.-P. Yu; unpublished results of this laboratory) and M. acetivorans rbcL genes were expressed in E. coli BL-21 (Stratagene), whereas recombinant M. jannaschii RubisCO was obtained from strain BL-21 Codon Plus. E. coli cultures expressing the A. fulgidus and M. acetivorans genes were grown in 2-liter flasks containing 1 liter of LB medium, with continuous shaking at 120 rpm at 37°C. When the cells reached an optical density at 660 nm of 0.5 to 0.6, the cells were shifted to a temperature of 42°C for 30 min. This artificial heat shock induces the E. coli chaperone system, which increases the amount of soluble, active recombinant protein. The culture was then shifted to 25°C, and isopropyl ß-D-galactopyranoside (IPTG) was added to a final concentration of 0.1 mM. Induction was continued overnight (15 h) at 25°C.
M. jannaschii recombinant RubisCO protein was produced in six 10-liter batch cultures of LB medium (Ohio State University Fermentation Facility). The airflow into the fermenter was 2.0 liters of air/min, with constant stirring of 120 rpm. Oxygen probe measurements proved that this airflow was adequate to maintain an oxygen-limited environment in the fermenter. Cultures were grown at 37°C until an optical density at 660 nm of 0.5 to 0.6 was reached and then were shifted to 42°C for 30 min. After cooling to 25°C, the culture was induced overnight as previously described. Following the addition of IPTG, the stirring rate was reduced to 80 rpm overnight. Cells were harvested aerobically by centrifugation and stored at -70°C.
The purification protocols prior to column chromatography were nearly identical for the two recombinant thermophilic RubisCO proteins from A. fulgidus and M. jannaschii. All manipulations were performed with buffers sparged thoroughly with argon gas. The cell pellets were resuspended in an anaerobic chamber in TEMMB buffer supplemented with DNase. The cells were disrupted in a French pressure cell (102,000 kPa), with the crude extract flowing into a sealed vial flushed with argon gas. The extracts were decanted into centrifuge tubes inside an anaerobic chamber. All centrifuge bottles contained a screw cap with an O-ring seal to assure proper sealing outside of the chamber. The cells were centrifuged at 16,000 x g and 4°C for 10 min. The supernatant was decanted inside an anaerobic chamber into new serum vials, which were subsequently pressurized to 10 lb/in2 with argon gas. The vials were placed into an 85°C water bath for 20 min with gentle shaking. After 20 min the extract was immediately placed on ice for 60 min. The extract was taken back into the chamber, decanted into anaerobic equilibrated centrifuge bottles, and centrifuged at 30,000 x g and 4°C for 30 min. Extracts were decanted into clean serum vials and frozen in an ethanol dry-ice bath and stored overnight at -70°C in preparation for column chromatography.
For purification of the M. acetivorans recombinant protein, the procedure was the same except that the heat step was altered for this mesophilic protein prior to column chromatography. After the first centrifugation, the MgCl2 concentration was increased to 50 mM with an anaerobic stock of 1.0 M MgCl2; the extract was heated to 50°C for 10 min and then transferred to ice for 1 h. Precipitated protein was removed by centrifugation.
Column chromatography was performed inside a chamber with a Bio-Rad BioLogic Workstation purification apparatus. Column fractions were collected in 1.0-ml volumes and assayed using the standard anaerobic RubisCO assay. The purification of the M. jannaschii RubisCO employed G-25 Superfine, DEAE FF, QSHP, and Superose 12 column chromatography. Purification of the recombinant A. fulgidus enzyme was similar to that of M. jannaschii RubisCO except that the G-25 Superfine and the DEAE FF columns were not used. The M. acetivorans RubisCO protein purification followed the same column order as the M. jannaschii enzyme, with the omission of G25 Superfine chromatography. Gel filtration standards were purchased from Bio-Rad (Hercules, Calif.) (catalogue number 151-1901). These standards were used to calibrate the 110-ml Superfine Gel Filtration column used in the above purification protocols. Purified enzymes (Fig. 1) were used to generate antibodies; the purified proteins were also utilized in some of the reported enzyme assays.
![]() View larger version (34K): [in a new window] |
FIG. 1. Purity of protein fractions eluted from Superose 12 gel filtration columns of recombinant RubisCO preparations from M. jannaschii (A), A. fulgidus (B), and M. acetivorans (C). Protein standards are shown in the leftmost lanes of panels A and B. SDS-PAGE was performed as described in Materials and Methods. Purified proteins were used to prepare antibodies of each enzyme as described in Materials and Methods.
|
Using BSA as a standard, protein concentrations were determined by the Lowry method (17).
Western immunoblot analysis using polyclonal antibodies to archaeal RubisCO proteins. The purity of each respective RubisCO protein was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (15) (Fig. 1). Antiserum directed against purified M. jannaschii RubisCO was prepared in rabbits by Cocalico Biologicals, Inc. (Reamstown, Pa.), and Western immunoblotting was used to test the specificity of the antiserum. Using a Transblot semidry transfer cell (Bio-Rad), proteins resolved by SDS-PAGE (15) were transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, Mass.) according to directions supplied by the manufacturer. Using antibodies directed against the archaeal RubisCO used, washes and incubations with antibodies were carried out at a dilution of 1:1,000 as described previously (32). Immunoblots were developed with Attophos detection reagent according to the manufacturer's instructions (Amersham, Buckinghamshire, England) and visualized with a Storm 840 imaging system (Molecular Dynamics, Sunnyvale, Calif.).
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Percent identity/percent similarity for several representative I, II, and III RubisCO proteins
|
![]() View larger version (58K): [in a new window] |
FIG. 2. Sequence alignment showing that the key catalytic residues important for RuBP-dependent CO2 fixation are maintained in the archaeal RubisCO proteins used in this study. The numbers represents the amino acid residues corresponding to the Synechococcus PCC 6301 form I protein. Residues known to be important for either catalysis (C) or RuBP binding (R) are indicated. I-Syn 6301, Synechococcus PCC 6301 form I; II-Rr, R. rubrum form II; III-Mj, Methanocaldococcus (Methanococcus) jannaschii form III; III-Af RbcL-2, A. fulgidus RbcL-2 form III; III-Ma, M. acetivorans form III; III-Mb, M. barkeri form III; III-Mm, M. mazei form III; III-Ph, Pyrococcus horikoshii form III; III-Tk, T. (Pyrococcus) kodakaraensis form III.
|
|
View this table: [in a new window] |
TABLE 3. RubisCO levels of crude extracts prepared from archaeaa
|
The presence of RubisCO in archaeal extracts was further investigated using antibodies directed against recombinant M. jannaschii RubisCO. The Western immunoblotting results (Fig. 3) clearly indicated that significant levels of M. jannaschii RubisCO protein were produced under normal growth conditions and optimal growth temperatures. It is interesting that the original whole-cell 14CO2 label incorporation studies performed with M. jannaschii did not indicate that [14C]phosphoglyceric acid was formed (indicative of RubisCO activity); however, these studies were performed at 65°C (28). Thus, growth experiments with M. jannaschii were repeated at the optimal growth temperature of 83°C and at 65°C, the same temperature at which the original label-incorporation studies had been performed. The Western blotting results (Fig. 3) demonstrated that significant amounts of RubisCO protein were produced by M. jannaschii at both temperatures.
![]() View larger version (40K): [in a new window] |
FIG. 3. Western immunoblot showing RubisCO protein accumulation in M. jannaschii with respect to growth temperature. The antiserum used in Western immunoblotting was generated against M. jannaschii recombinant RubisCO protein purified from E. coli. (A) Purified recombinant M. jannaschii RubisCO (3 µg) from E. coli grown at 37°C; (B) crude extract (49 µg) prepared from M. jannaschii grown at 65°C; (C) crude extract (49 µg) prepared from M. jannaschii grown at 85°C.
|
Antibodies to recombinant M. acetivorans RubisCO verified that the mutant strain did not synthesize the protein (data not shown).
Recombinant archaeal RubisCO. The rbcL genes of M. jannaschii, A. fulgidus, and M. acetivorans were each expressed in E. coli, and recombinant proteins were purified to homogeneity (Fig. 1). In all three cases, the proteins were found to be homodimers of large subunits, in keeping with the nature of the enzyme synthesized by M. jannaschii itself and in agreement with previous results with the M. jannaschii recombinant protein (35). The activity of purified recombinant M. jannaschii and A. fulgidus RubisCO was examined with respect to assay temperature. Recombinant M. jannaschii RubisCO did not exhibit detectable activity at room temperature, and incorporation of 14CO2 into acid-stable labeled product was barely detectable at 65°C compared to that seen at the optimal temperature of 85°C (Fig. 4A). In addition, there was a notable lag time of about 5 min before significant activity ensued and became linear with time. The narrow temperature range for catalytic activity for the M. jannaschii enzyme contrasted to that seen with A. fulgidus RubisCO (Fig. 4B), as this protein catalyzed activity over a very broad temperature range (12). It was also apparent that the A. fulgidus enzyme did not exhibit a time-dependent lag in activity.
![]() View larger version (14K): [in a new window] |
FIG. 4. Activity time course for purified recombinant M. jannaschii RubisCO assayed at 65°C ( ) and 85°C ( ) (A) and A. fulgidus RubisCO assayed at 90°C ( ), 65°C ( ), and 37°C ( ) (B). Each assay contained 5 µg of protein and was performed under anaerobic conditions; no activity was detected at 37°C for the M. jannaschii enzyme.
|
![]() View larger version (13K): [in a new window] |
FIG. 5. Exposure of recombinant M. jannaschii, A. fulgidus, and M. acetivorans RubisCO to oxygen (2.5 µg of protein in all cases). M. jannaschii (A) and A. fulgidus (B) RubisCO were assayed at 83°C, while M. acetivorans RubisCO (C) was assayed at 37°C. The aerobic assay ( ) was performed in vials in the presence of ambient air, whereas the anaerobic assay ( ) was carried out under an argon atmosphere. The recovered assay ( ) represents an assay in which a continuous stream of oxygen was allowed to permeate the assay vial headspace for 45 min; the oxygen-exposed enzyme was then injected into an anaerobic vial and assayed for the indicated times.
|
Complementation of bacterial RubisCO deletion mutants with the M. acetivorans rbcL gene. RubisCO deletion mutants of R. capsulatus and R sphaeroides cannot grow under photoheterotrophic or photoautotrophic conditions. Initial attempts to complement the RubisCO deletion mutants of R. capsulatus (strain SBI-II-) and R. sphaeroides (strain 16) with the M. jannaschii rbcL gene failed (data not shown). Lack of complementation was most likely due to the fact that while R. sphaeroides and R. capsulatus grow at 30°C, the M. jannaschii RubisCO shows little or no activity at temperatures at or below 65°C (Fig. 4). However, RubisCO from the mesophile M. acetivorans was shown to be active at 25 to 40°C (results not shown). Thus, expression of the M. acetivorans rbcL gene in Rhodobacter RubisCO knockout strains afforded an opportunity to test whether the archaeal enzyme can function in a physiological background where it would be required to support growth. This was deemed the ultimate test of the functionality of archaeal RubisCO. It was shown that expression of the M. acetivorans rbcL gene in R. capsulatus strain SBI-II- complemented growth under anaerobic photoheterotrophic conditions with cultures bubbled with argon gas (Fig. 6A). No special precautions were taken to eliminate or scrub vestiges of oxygen from the gas atmosphere in these growth experiments, and it appeared that photoheterotrophic cultures of complemented R. capsulatus strain SBI-II- took some time to even approach the growth rate of wild-type R. sphaeroides under these conditions.
![]() View larger version (14K): [in a new window] |
FIG. 6. Complementation and growth of R. capsulatus cbbLS/cbbM knockout strain (form I [cbbLS] and II [cbbM] RubisCO genes deleted) SBI-II- (22) at the expense of the M. acetivorans RubisCO (rbcL) gene in plasmid pRPSMCS3MA. (A) Using malate as the carbon source, photoheterotrophic cultures were grown in glass bottles continuously bubbled with argon (without scrubbing the gas through a heated-copper-filings system) to remove trace amounts of oxygen. , R. capsulatus strain SBI-II-; , R. capsulatus strain SBI-II- containing plasmid pRPSMCS3MA; , wild-type R. sphaeroides strain HR containing plasmid pRPSMCS3MA. (B) Photoautotrophic growth of R. capsulatus knockout strain SBI-II- (cbbLS/cbbM) ( ) along with wild-type R. sphaeroides HR ( ) and R. sphaeroides knockout strain 16 (cbbLS/cbbM) ( ), all containing plasmid pRPSMCS3MA. The cells were grown in sealed and crimped tubes pressurized with oxygen-free 20% CO2 balanced with H2. The gas was exchanged every 24 h.
|
Finally, Western immunoblot experiments provided further evidence that the M. acetivorans gene was expressed in the R. capsulatus and R. sphaeroides RubisCO deletion strains under anaerobic phototrophic growth conditions. Levels of protein produced were consistent with known regulatory features of the cbb promoter of the vector employed under the indicated growth conditions (Fig. 7). Under photoheterotrophic growth conditions and, to a lesser extent, under photoautotrophic growth conditions, extracts from complemented R. sphaeroides strain 16 appeared to contain low-molecular-mass cross-reactive protein species that were perhaps indicative of proteolysis (Fig. 7, lanes F and G). This result was not so apparent for complemented R. capsulatus (Fig. 7, lanes D and E).
![]() View larger version (60K): [in a new window] |
FIG. 7. Western immunoblot of extracts of R. capsulatus SBI-II- and R. sphaeroides strain 16 complemented with plasmid pRPSMCS3MA (containing M. acetivorans rbcL). The immunoblot was tested using antibodies directed against purified recombinant M. acetivorans RubisCO. All lanes contained soluble crude extract prepared from stationary phase cultures from the following strains: photoheterotrophically grown wild-type R. sphaeroides strain HR (lane A); photoautotrophically grown wild-type R. sphaeroides strain HR (lane B); purified recombinant M. acetivorans RubisCO (lane C); photoheterotrophically grown R. capsulatus SBI-II- complemented with plasmid pRPSMCS3MA (containing M. acetivorans rbcL) (lane D); photoautotrophically grown R. capsulatus SBI-II- complemented with plasmid pRPSMCS3MA (lane E); photoautotrophically grown R. sphaeroides strain 16 complemented with plasmid pRPSMCS3MA (lane F); photoheterotrophically grown R. sphaeroides strain 16 complemented with plasmid pRPSMCS3MA (lane G); photoheterotrophically grown wild-type R. capsulatus strain SB1003 (lane H); and purified recombinant M. acetivorans RubisCO (lane I). Each lane received approximately 15 µg of protein.
|
|
|
|---|
With respect to M. jannaschii, the original labeling experiments might have missed potential whole-cell evidence for RubisCO activity because the cells were grown at 65°C (28), a temperature at which this enzyme shows poor activity in vitro. Thus, it might be useful to consider performing similar label incorporation studies at optimum temperatures for both growth and enzyme activity (83 to 85°C). Interesting yet puzzling is the fact that RubisCO protein accumulation appeared to be independent of whether M. jannaschii was grown at 65 or 83°C. The two thermophilic form III RubisCO proteins, from A. fulgidus and M. jannaschii, also showed great differences in the range of temperature-dependent activity; they certainly differed from the mesophilic enzyme from M. acetivorans in this respect. That the A. fulgidus enzyme retained activity at the same temperature as the M. acetivorans RubisCO might lead to potential future structure-function studies related to defining structural requirements for thermostability.
Other interesting properties relate to the differential effect of oxygen exposure. Both the M. jannaschii (35) and A. fulgidus RubisCO were reversibly inhibited by oxygen. For RubisCO, oxygen is classically known to be a competitive inhibitor with respect to carbon dioxide (30); however, in no instance have air levels of oxygen been shown to inhibit form I or form II RubisCO at the saturating levels of CO2 employed in normal assays. Previous work had shown that the M. jannaschii RubisCO can use oxygen as a gaseous substrate and form phosphoglycolate (35); however, the enzyme is rapidly inactivated under these conditions, as shown in this study as well. While not directly addressed, it may be that the archaeal enzymes considered here have extremely high affinities for oxygen or there may be some special way in which oxygen interacts with the M. jannaschii and A. fulgidus proteins. Whatever the mechanism for reversible oxygen inhibition, clearly the mesophilic M. acetivorans enzyme behaved differently, as this enzyme did not recover from oxygen inactivation under the experimental conditions reported.
Future work should address the differential effects of oxygen on these proteins, since the molecular basis for RubisCO's interaction with oxygen is fundamental to elucidating the mechanism of CO2/O2 specificity (10). It should also be noted that, unlike the three RubisCO enzymes studied here, the recombinant T. kodakaraensis KOD1 RubisCO does not appear to be sensitive to oxygen (6); however, it is not clear how the T. kodakaraensis enzyme was assayed in the cited study. Furthermore, based on room temperature gel filtration studies, each of the enzymes of this study is a homodimer and thus quite different from the T. kodakaraensis enzyme, which shows an unusual and very interesting pentameric structure (13, 16). These previous studies, along with the present investigation, indicate that form III RubisCO proteins comprise a highly divergent group with respect to catalytic and structural properties. This is probably reflective of the rather low primary structural identity of proteins from this class (Table 2).
Complementation of RubisCO knockout strains of R. capsulatus and R. sphaeroides with the mesophilic archaeal rbcL gene from M. acetivorans provided excellent evidence that this RubisCO was functional in an environment where all other required CBB intermediates are known to be present. This result, plus the fact that enzymatic activity and immunological evidence for the archaeal enzymes were demonstrable in crude extracts from the native organisms, strongly suggested that these organisms produce active RubisCO. The absence of any known purpose for archaeal RubisCO in primary CO2 fixation could mean that this enzyme has some other function in these organisms. Unfortunately, the phenotype of the rbcL strain of M. acetivorans has yet to provide any clue as to the function of RubisCO in these organisms. The M. acetivorans rbcL knockout strain (strain 4555) prepared by W. Metcalf (18) was fully capable of using its preferred growth substrates, namely, acetate, methanol, or trimethylamine, with no noticeable difference in growth rate compared to the wild type, yet RubisCO activity and immunoreactive protein were clearly absent in this strain (data not shown).
As a result of the findings of this study and an earlier investigation (35), it is apparent that oxygen inhibited archaeal RubisCO activity; yet it is also apparent that O2 can serve as a substrate, albeit weakly (35). From these results, it can be suggested that the archaeal enzyme functions in some oxygen-scavenging capacity in vivo. However, this seemed unlikely in light of the oxygen sensitivity of the three archaeal enzymes studied here as well as the strict anaerobic requirement for photoautotrophic growth of RubisCO knockout strains of Rhodobacter complemented with M. acetivorans rbcL. In addition, the biphasic growth of argon-bubbled photoheterotrophic cultures of complemented strain R. capsulatus SBI-II- appears to further discount the oxygen-scavenging theory. Complemented photoheterotrophic-grown cultures were not strictly anaerobic, as the argon gas used to bubble cultures was not scrubbed to remove vestiges of oxygen. Normally, this is not a problem with typical form I or form II proteins, because these enzymes are not overly sensitive to oxygen. Thus, the achievement of nearly exponential photoheterotrophic growth by the complemented culture only after 7 to 10 days may reflect the fact that this facultative anaerobe removed inhibitory levels of oxygen only after the culture density reached some defined level.
Speculations as to the function of RubisCO in anaerobic archaea must also contend with the means by which these organisms synthesize the substrate RuBP. This is particularly relevant, as there is no other known potential CO2 acceptor for RubisCO beyond RuBP. We entertained the possibility that the archaeal enzyme might be unusual in this regard and might use other potential and structurally similar sugar phosphates or perhaps other acceptor molecules. No substrate other than RuBP served as a substrate for the archaeal enzyme. In addition, attempts to demonstrate the presence of PRK activity in extracts of these organisms or to extract RuBP from these cells have also consistently failed (M. W. Finn and F. R. Tabita, unpublished observations). Of course, as discussed in the introduction, there is no homologous PRK sequence that can be found in any available archaeal genome. It may be that we are unable to recognize a potentially unusual type of PRK, since sequences of this enzyme have not been studied or compared to the extent that those of RubisCO have been. In addition, the various methods used thus far to extract RuBP from M. jannaschii may have failed because levels are not high enough for detection in these organisms or because the extraction methods do not work in archaea. It is also possible that the failure to detect PRK by homology searches or enzyme assay means that alternative pathways leading to the synthesis of RuBP exist in anaerobic archaea. Current work is thus focused at elucidating potential alternative routes for RuBP synthesis. Resolution of these very interesting and perplexing questions would also undoubtedly invite intriguing evolutionary speculations, especially if anaerobic archaea are shown to fix CO2 by the use of RuBP as the CO2 acceptor while gaining energy and assimilating most of the CO2 required for growth by established methanogenesis pathways.
This study was supported by National Institutes of Health grant GM24497.
|
|
|---|
H: functional analysis and comparative genomics. J. Bacteriol. 179:7135-7155.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»